Anti-synthetase Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-11-03
Clinical Trial Update: A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) [Phase 2]
Amgen completed a Phase 2 proof-of-concept trial evaluating the efficacy and safety of Daxdilimab in Dermatomyositis and anti-synthetase inf…